APO Research
Talk to an analyst

APO RESEARCH · REPORT

PD-1/PD-L1 Checkpoint Inhibitors

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global PD-1/PD-L1 Checkpoint Inhibitors Industry Growth and Trends Forecast to 2032

28 December 202594 pages

Choose your research edition.

Industry ResearchPD-1/PD-L1 Checkpoint Inhibitors Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal PD-1/PD-L1 Checkpoint Inhibitors Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal PD-1/PD-L1 Checkpoint Inhibitors Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal PD-1/PD-L1 Checkpoint Inhibitors Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal PD-1/PD-L1 Checkpoint Inhibitors Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global PD-1/PD-L1 Checkpoint Inhibitors market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for PD-1/PD-L1 Checkpoint Inhibitors is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for PD-1/PD-L1 Checkpoint Inhibitors is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for PD-1/PD-L1 Checkpoint Inhibitors is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of PD-1/PD-L1 Checkpoint Inhibitors include Merck, Junshi Biosciences, Pfizer, Hengrui Pharmaceuticals, Roche, Regeneron Pharmaceuticals, Bristol Myers Squibb and AstraZeneca, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global PD-1/PD-L1 Checkpoint Inhibitors market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The PD-1/PD-L1 Checkpoint Inhibitors market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global PD-1/PD-L1 Checkpoint Inhibitors market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to PD-1/PD-L1 Checkpoint Inhibitors.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global PD-1/PD-L1 Checkpoint Inhibitors market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

PD-1/PD-L1 Checkpoint Inhibitors Market by Company

Merck

Junshi Biosciences

Pfizer

Hengrui Pharmaceuticals

Roche

Regeneron Pharmaceuticals

Bristol Myers Squibb

AstraZeneca

PD-1/PD-L1 Checkpoint Inhibitors Segment by Type

PD-1 Inhibitors

PD-L1 Inhibitors

PD-1/PD-L1 Checkpoint Inhibitors Segment by Application

Gastric Cancer

Squamous Cell Skin Cancer

Melanoma

Non-small Cell Lung Cancer

Other

PD-1/PD-L1 Checkpoint Inhibitors Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global PD-1/PD-L1 Checkpoint Inhibitors market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of PD-1/PD-L1 Checkpoint Inhibitors and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of PD-1/PD-L1 Checkpoint Inhibitors.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of PD-1/PD-L1 Checkpoint Inhibitors manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of PD-1/PD-L1 Checkpoint Inhibitors in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of PD-1 Inhibitors Table 2. Major Company of PD-L1 Inhibitors Table 3. Global PD-1/PD-L1 Checkpoint Inhibitors Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global PD-1/PD-L1 Checkpoint Inhibitors Sales by Type (2021-2026) & (K Units) Table 5. Global PD-1/PD-L1 Checkpoint Inhibitors Sales Market Share in Volume by Type (2021-2026) Table 6. Global PD-1/PD-L1 Checkpoint Inhibitors Sales by Type (2021-2026) & (US$ Million) Table 7. Global PD-1/PD-L1 Checkpoint Inhibitors Sales Market Share in Value by Type (2021-2026) Table 8. Global PD-1/PD-L1 Checkpoint Inhibitors Price by Type (2021-2026) & (US$/Unit) Table 9. Global PD-1/PD-L1 Checkpoint Inhibitors Sales by Type (2027-2032) & (K Units) Table 10. Global PD-1/PD-L1 Checkpoint Inhibitors Sales Market Share in Volume by Type (2027-2032) Table 11. Global PD-1/PD-L1 Checkpoint Inhibitors Sales by Type (2027-2032) & (US$ Million) Table 12. Global PD-1/PD-L1 Checkpoint Inhibitors Sales Market Share in Value by Type (2027-2032) Table 13. Global PD-1/PD-L1 Checkpoint Inhibitors Price by Type (2027-2032) & (US$/Unit) Table 14. North America PD-1/PD-L1 Checkpoint Inhibitors Sales by Type (2021-2026) & (K Units) Table 15. North America PD-1/PD-L1 Checkpoint Inhibitors Sales by Type (2021-2026) & (US$ Million) Table 16. Europe PD-1/PD-L1 Checkpoint Inhibitors Sales by Type (2021-2026) & (K Units) Table 17. Europe PD-1/PD-L1 Checkpoint Inhibitors Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific PD-1/PD-L1 Checkpoint Inhibitors Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific PD-1/PD-L1 Checkpoint Inhibitors Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America PD-1/PD-L1 Checkpoint Inhibitors Sales by Type (2021-2026) & (K Units) Table 21. Latin America PD-1/PD-L1 Checkpoint Inhibitors Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa PD-1/PD-L1 Checkpoint Inhibitors Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa PD-1/PD-L1 Checkpoint Inhibitors Sales by Type (2021-2026) & (US$ Million) Table 24. PD-1/PD-L1 Checkpoint Inhibitors Industry Trends Table 25. PD-1/PD-L1 Checkpoint Inhibitors Industry Drivers Table 26. PD-1/PD-L1 Checkpoint Inhibitors Industry Opportunities and Challenges Table 27. PD-1/PD-L1 Checkpoint Inhibitors Industry Restraints Table 28. Global PD-1/PD-L1 Checkpoint Inhibitors Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global PD-1/PD-L1 Checkpoint Inhibitors Revenue Market Share by Company (2021-2026) Table 30. Global PD-1/PD-L1 Checkpoint Inhibitors Sales by Company (2021-2026) & (K Units) Table 31. Global PD-1/PD-L1 Checkpoint Inhibitors Sales Share by Company (2021-2026) Table 32. Global PD-1/PD-L1 Checkpoint Inhibitors Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global PD-1/PD-L1 Checkpoint Inhibitors Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global PD-1/PD-L1 Checkpoint Inhibitors Major Company Production Sites and Headquarters Table 35. Global PD-1/PD-L1 Checkpoint Inhibitors Company, Product Type & Application Table 36. Global PD-1/PD-L1 Checkpoint Inhibitors Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global PD-1/PD-L1 Checkpoint Inhibitors by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global PD-1/PD-L1 Checkpoint Inhibitors Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global PD-1/PD-L1 Checkpoint Inhibitors Sales by Region (2021-2026) & (K Units) Table 41. Global PD-1/PD-L1 Checkpoint Inhibitors Sales Market Share in Volume by Region (2021-2026) Table 42. Global PD-1/PD-L1 Checkpoint Inhibitors Sales by Region (2021-2026) & (US$ Million) Table 43. Global PD-1/PD-L1 Checkpoint Inhibitors Sales Market Share in Value by Region (2021-2026) Table 44. Global PD-1/PD-L1 Checkpoint Inhibitors Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global PD-1/PD-L1 Checkpoint Inhibitors Sales by Region (2027-2032) & (K Units) Table 46. Global PD-1/PD-L1 Checkpoint Inhibitors Sales Market Share in Volume by Region (2027-2032) Table 47. Global PD-1/PD-L1 Checkpoint Inhibitors Sales by Region (2027-2032) & (US$ Million) Table 48. Global PD-1/PD-L1 Checkpoint Inhibitors Sales Market Share in Value by Region (2027-2032) Table 49. Global PD-1/PD-L1 Checkpoint Inhibitors Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global PD-1/PD-L1 Checkpoint Inhibitors Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global PD-1/PD-L1 Checkpoint Inhibitors Sales by Application (2021-2026) & (K Units) Table 52. Global PD-1/PD-L1 Checkpoint Inhibitors Sales Market Share in Volume by Application (2021-2026) Table 53. Global PD-1/PD-L1 Checkpoint Inhibitors Sales by Application (2021-2026) & (US$ Million) Table 54. Global PD-1/PD-L1 Checkpoint Inhibitors Sales Market Share in Value by Application (2021-2026) Table 55. Global PD-1/PD-L1 Checkpoint Inhibitors Price by Application (2021-2026) & (US$/Unit) Table 56. Global PD-1/PD-L1 Checkpoint Inhibitors Sales by Application (2027-2032) & (K Units) Table 57. Global PD-1/PD-L1 Checkpoint Inhibitors Sales Market Share in Volume by Application (2027-2032) Table 58. Global PD-1/PD-L1 Checkpoint Inhibitors Sales by Application (2027-2032) & (US$ Million) Table 59. Global PD-1/PD-L1 Checkpoint Inhibitors Sales Market Share in Value by Application (2027-2032) Table 60. Global PD-1/PD-L1 Checkpoint Inhibitors Price by Application (2027-2032) & (US$/Unit) Table 61. North America PD-1/PD-L1 Checkpoint Inhibitors Sales by Application (2021-2026) & (K Units) Table 62. North America PD-1/PD-L1 Checkpoint Inhibitors Sales by Application (2021-2026) & (US$ Million) Table 63. Europe PD-1/PD-L1 Checkpoint Inhibitors Sales by Application (2021-2026) & (K Units) Table 64. Europe PD-1/PD-L1 Checkpoint Inhibitors Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific PD-1/PD-L1 Checkpoint Inhibitors Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific PD-1/PD-L1 Checkpoint Inhibitors Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America PD-1/PD-L1 Checkpoint Inhibitors Sales by Application (2021-2026) & (K Units) Table 68. Latin America PD-1/PD-L1 Checkpoint Inhibitors Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa PD-1/PD-L1 Checkpoint Inhibitors Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa PD-1/PD-L1 Checkpoint Inhibitors Sales by Application (2021-2026) & (US$ Million) Table 71. Merck Company Information Table 72. Merck Business Overview Table 73. Merck PD-1/PD-L1 Checkpoint Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Merck PD-1/PD-L1 Checkpoint Inhibitors Product Portfolio Table 75. Merck Recent Development Table 76. Junshi Biosciences Company Information Table 77. Junshi Biosciences Business Overview Table 78. Junshi Biosciences PD-1/PD-L1 Checkpoint Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Junshi Biosciences PD-1/PD-L1 Checkpoint Inhibitors Product Portfolio Table 80. Junshi Biosciences Recent Development Table 81. Pfizer Company Information Table 82. Pfizer Business Overview Table 83. Pfizer PD-1/PD-L1 Checkpoint Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Pfizer PD-1/PD-L1 Checkpoint Inhibitors Product Portfolio Table 85. Pfizer Recent Development Table 86. Hengrui Pharmaceuticals Company Information Table 87. Hengrui Pharmaceuticals Business Overview Table 88. Hengrui Pharmaceuticals PD-1/PD-L1 Checkpoint Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Hengrui Pharmaceuticals PD-1/PD-L1 Checkpoint Inhibitors Product Portfolio Table 90. Hengrui Pharmaceuticals Recent Development Table 91. Roche Company Information Table 92. Roche Business Overview Table 93. Roche PD-1/PD-L1 Checkpoint Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Roche PD-1/PD-L1 Checkpoint Inhibitors Product Portfolio Table 95. Roche Recent Development Table 96. Regeneron Pharmaceuticals Company Information Table 97. Regeneron Pharmaceuticals Business Overview Table 98. Regeneron Pharmaceuticals PD-1/PD-L1 Checkpoint Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Regeneron Pharmaceuticals PD-1/PD-L1 Checkpoint Inhibitors Product Portfolio Table 100. Regeneron Pharmaceuticals Recent Development Table 101. Bristol Myers Squibb Company Information Table 102. Bristol Myers Squibb Business Overview Table 103. Bristol Myers Squibb PD-1/PD-L1 Checkpoint Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Bristol Myers Squibb PD-1/PD-L1 Checkpoint Inhibitors Product Portfolio Table 105. Bristol Myers Squibb Recent Development Table 106. AstraZeneca Company Information Table 107. AstraZeneca Business Overview Table 108. AstraZeneca PD-1/PD-L1 Checkpoint Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. AstraZeneca PD-1/PD-L1 Checkpoint Inhibitors Product Portfolio Table 110. AstraZeneca Recent Development Table 111. North America PD-1/PD-L1 Checkpoint Inhibitors Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 112. North America PD-1/PD-L1 Checkpoint Inhibitors Sales by Country (2021-2026) & (K Units) Table 113. North America PD-1/PD-L1 Checkpoint Inhibitors Sales Market Share by Country (2021-2026) Table 114. North America PD-1/PD-L1 Checkpoint Inhibitors Sales Forecast by Country (2027-2032) & (K Units) Table 115. North America PD-1/PD-L1 Checkpoint Inhibitors Sales Market Share Forecast by Country (2027-2032) Table 116. North America PD-1/PD-L1 Checkpoint Inhibitors Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. North America PD-1/PD-L1 Checkpoint Inhibitors Market Size by Country (2021-2026) & (US$ Million) Table 118. North America PD-1/PD-L1 Checkpoint Inhibitors Market Share by Country (2021-2026) Table 119. North America PD-1/PD-L1 Checkpoint Inhibitors Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. North America PD-1/PD-L1 Checkpoint Inhibitors Market Share Forecast by Country (2027-2032) Table 121. Europe PD-1/PD-L1 Checkpoint Inhibitors Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 122. Europe PD-1/PD-L1 Checkpoint Inhibitors Sales by Country (2021-2026) & (K Units) Table 123. Europe PD-1/PD-L1 Checkpoint Inhibitors Sales Market Share by Country (2021-2026) Table 124. Europe PD-1/PD-L1 Checkpoint Inhibitors Sales Forecast by Country (2027-2032) & (K Units) Table 125. Europe PD-1/PD-L1 Checkpoint Inhibitors Sales Market Share Forecast by Country (2027-2032) Table 126. Europe PD-1/PD-L1 Checkpoint Inhibitors Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Europe PD-1/PD-L1 Checkpoint Inhibitors Market Size by Country (2021-2026) & (US$ Million) Table 128. Europe PD-1/PD-L1 Checkpoint Inhibitors Market Share by Country (2021-2026) Table 129. Europe PD-1/PD-L1 Checkpoint Inhibitors Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Europe PD-1/PD-L1 Checkpoint Inhibitors Market Share Forecast by Country (2027-2032) Table 131. Asia-Pacific PD-1/PD-L1 Checkpoint Inhibitors Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 132. Asia-Pacific PD-1/PD-L1 Checkpoint Inhibitors Sales by Country (2021-2026) & (K Units) Table 133. Asia-Pacific PD-1/PD-L1 Checkpoint Inhibitors Sales Market Share by Country (2021-2026) Table 134. Asia-Pacific PD-1/PD-L1 Checkpoint Inhibitors Sales Forecast by Country (2027-2032) & (K Units) Table 135. Asia-Pacific PD-1/PD-L1 Checkpoint Inhibitors Sales Market Share Forecast by Country (2027-2032) Table 136. Asia-Pacific PD-1/PD-L1 Checkpoint Inhibitors Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Asia-Pacific PD-1/PD-L1 Checkpoint Inhibitors Market Size by Country (2021-2026) & (US$ Million) Table 138. Asia-Pacific PD-1/PD-L1 Checkpoint Inhibitors Market Share by Country (2021-2026) Table 139. Asia-Pacific PD-1/PD-L1 Checkpoint Inhibitors Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Asia-Pacific PD-1/PD-L1 Checkpoint Inhibitors Market Share Forecast by Country (2027-2032) Table 141. Latin America PD-1/PD-L1 Checkpoint Inhibitors Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 142. Latin America PD-1/PD-L1 Checkpoint Inhibitors Sales by Country (2021-2026) & (K Units) Table 143. Latin America PD-1/PD-L1 Checkpoint Inhibitors Sales Market Share by Country (2021-2026) Table 144. Latin America PD-1/PD-L1 Checkpoint Inhibitors Sales Forecast by Country (2027-2032) & (K Units) Table 145. Latin America PD-1/PD-L1 Checkpoint Inhibitors Sales Market Share Forecast by Country (2027-2032) Table 146. Latin America PD-1/PD-L1 Checkpoint Inhibitors Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Latin America PD-1/PD-L1 Checkpoint Inhibitors Market Size by Country (2021-2026) & (US$ Million) Table 148. Latin America PD-1/PD-L1 Checkpoint Inhibitors Market Share by Country (2021-2026) Table 149. Latin America PD-1/PD-L1 Checkpoint Inhibitors Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Latin America PD-1/PD-L1 Checkpoint Inhibitors Market Share Forecast by Country (2027-2032) Table 151. Middle East and Africa PD-1/PD-L1 Checkpoint Inhibitors Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 152. Middle East and Africa PD-1/PD-L1 Checkpoint Inhibitors Sales by Country (2021-2026) & (K Units) Table 153. Middle East and Africa PD-1/PD-L1 Checkpoint Inhibitors Sales Market Share by Country (2021-2026) Table 154. Middle East and Africa PD-1/PD-L1 Checkpoint Inhibitors Sales Forecast by Country (2027-2032) & (K Units) Table 155. Middle East and Africa PD-1/PD-L1 Checkpoint Inhibitors Sales Market Share Forecast by Country (2027-2032) Table 156. Middle East and Africa PD-1/PD-L1 Checkpoint Inhibitors Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Middle East and Africa PD-1/PD-L1 Checkpoint Inhibitors Market Size by Country (2021-2026) & (US$ Million) Table 158. Middle East and Africa PD-1/PD-L1 Checkpoint Inhibitors Market Share by Country (2021-2026) Table 159. Middle East and Africa PD-1/PD-L1 Checkpoint Inhibitors Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Middle East and Africa PD-1/PD-L1 Checkpoint Inhibitors Market Share Forecast by Country (2027-2032) Table 161. Key Raw Materials Table 162. Raw Materials Key Suppliers Table 163. PD-1/PD-L1 Checkpoint Inhibitors Distributors List Table 164. PD-1/PD-L1 Checkpoint Inhibitors Customers List Table 165. Research Programs/Design for This Report Table 166. Authors List of This Report Table 167. Secondary Sources Table 168. Primary Sources List of Figures Figure 1. PD-1/PD-L1 Checkpoint Inhibitors Image Figure 2. Global PD-1/PD-L1 Checkpoint Inhibitors Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global PD-1/PD-L1 Checkpoint Inhibitors Market Size (2021-2032) & (US$ Million) Figure 4. Global PD-1/PD-L1 Checkpoint Inhibitors Sales (2021-2032) & (K Units) Figure 5. PD-1 Inhibitors Image Figure 6. Global PD-1 Inhibitors Sales YoY Growth (2021-2032) & (K Units) Figure 7. PD-L1 Inhibitors Image Figure 8. Global PD-L1 Inhibitors Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global PD-1/PD-L1 Checkpoint Inhibitors Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global PD-1/PD-L1 Checkpoint Inhibitors Market Share by Type 2025 VS 2032 Figure 11. North America PD-1/PD-L1 Checkpoint Inhibitors Sales Market Share in Volume by Type in 2025 Figure 12. North America PD-1/PD-L1 Checkpoint Inhibitors Sales Market Share in Value by Type in 2025 Figure 13. Europe PD-1/PD-L1 Checkpoint Inhibitors Sales Market Share in Volume by Type in 2025 Figure 14. Europe PD-1/PD-L1 Checkpoint Inhibitors Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific PD-1/PD-L1 Checkpoint Inhibitors Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific PD-1/PD-L1 Checkpoint Inhibitors Sales Market Share in Value by Type in 2025 Figure 17. Latin America PD-1/PD-L1 Checkpoint Inhibitors Sales Market Share in Volume by Type in 2025 Figure 18. Latin America PD-1/PD-L1 Checkpoint Inhibitors Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa PD-1/PD-L1 Checkpoint Inhibitors Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa PD-1/PD-L1 Checkpoint Inhibitors Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 PD-1/PD-L1 Checkpoint Inhibitors Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Gastric Cancer Image Figure 24. Global Gastric Cancer Sales YoY Growth (2021-2032) & (K Units) Figure 25. Squamous Cell Skin Cancer Image Figure 26. Global Squamous Cell Skin Cancer Sales YoY Growth (2021-2032) & (K Units) Figure 27. Melanoma Image Figure 28. Global Melanoma Sales YoY Growth (2021-2032) & (K Units) Figure 29. Non-small Cell Lung Cancer Image Figure 30. Global Non-small Cell Lung Cancer Sales YoY Growth (2021-2032) & (K Units) Figure 31. Other Image Figure 32. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 33. Global PD-1/PD-L1 Checkpoint Inhibitors Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global PD-1/PD-L1 Checkpoint Inhibitors Market Share by Application 2025 VS 2032 Figure 35. North America PD-1/PD-L1 Checkpoint Inhibitors Sales Market Share in Volume by Application in 2025 Figure 36. North America PD-1/PD-L1 Checkpoint Inhibitors Sales Market Share in Value by Application in 2025 Figure 37. Europe PD-1/PD-L1 Checkpoint Inhibitors Sales Market Share in Volume by Application in 2025 Figure 38. Europe PD-1/PD-L1 Checkpoint Inhibitors Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific PD-1/PD-L1 Checkpoint Inhibitors Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific PD-1/PD-L1 Checkpoint Inhibitors Sales Market Share in Value by Application in 2025 Figure 41. Latin America PD-1/PD-L1 Checkpoint Inhibitors Sales Market Share in Volume by Application in 2025 Figure 42. Latin America PD-1/PD-L1 Checkpoint Inhibitors Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa PD-1/PD-L1 Checkpoint Inhibitors Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa PD-1/PD-L1 Checkpoint Inhibitors Sales Market Share in Value by Application in 2025 Figure 45. North America PD-1/PD-L1 Checkpoint Inhibitors Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. North America PD-1/PD-L1 Checkpoint Inhibitors Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America PD-1/PD-L1 Checkpoint Inhibitors Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America PD-1/PD-L1 Checkpoint Inhibitors Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe PD-1/PD-L1 Checkpoint Inhibitors Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Europe PD-1/PD-L1 Checkpoint Inhibitors Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe PD-1/PD-L1 Checkpoint Inhibitors Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe PD-1/PD-L1 Checkpoint Inhibitors Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific PD-1/PD-L1 Checkpoint Inhibitors Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Asia-Pacific PD-1/PD-L1 Checkpoint Inhibitors Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific PD-1/PD-L1 Checkpoint Inhibitors Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific PD-1/PD-L1 Checkpoint Inhibitors Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America PD-1/PD-L1 Checkpoint Inhibitors Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Latin America PD-1/PD-L1 Checkpoint Inhibitors Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America PD-1/PD-L1 Checkpoint Inhibitors Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America PD-1/PD-L1 Checkpoint Inhibitors Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa PD-1/PD-L1 Checkpoint Inhibitors Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Middle East and Africa PD-1/PD-L1 Checkpoint Inhibitors Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa PD-1/PD-L1 Checkpoint Inhibitors Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa PD-1/PD-L1 Checkpoint Inhibitors Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. PD-1/PD-L1 Checkpoint Inhibitors Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. PD-1/PD-L1 Checkpoint Inhibitors Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • PD-1 Inhibitors
  • PD-L1 Inhibitors
Applications
  • Gastric Cancer
  • Squamous Cell Skin Cancer
  • Melanoma
  • Non-small Cell Lung Cancer
  • Other
Companies covered
  • Merck
  • Junshi Biosciences
  • Pfizer
  • Hengrui Pharmaceuticals
  • Roche
  • Regeneron Pharmaceuticals
  • Bristol Myers Squibb
  • AstraZeneca

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global PD-1/PD-L1 Checkpoint Inhibitors Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global PD-1/PD-L1 Checkpoint Inhibitors Sales Estimates and Forecasts (2021-2032)
  5. 1.3 PD-1/PD-L1 Checkpoint Inhibitors Market by Type
  6. 1.3.1 PD-1 Inhibitors
  7. 1.3.2 PD-L1 Inhibitors
  8. 1.4 Global PD-1/PD-L1 Checkpoint Inhibitors Market Size by Type
  9. 1.4.1 Global PD-1/PD-L1 Checkpoint Inhibitors Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global PD-1/PD-L1 Checkpoint Inhibitors Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global PD-1/PD-L1 Checkpoint Inhibitors Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America PD-1/PD-L1 Checkpoint Inhibitors Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe PD-1/PD-L1 Checkpoint Inhibitors Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific PD-1/PD-L1 Checkpoint Inhibitors Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America PD-1/PD-L1 Checkpoint Inhibitors Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa PD-1/PD-L1 Checkpoint Inhibitors Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 PD-1/PD-L1 Checkpoint Inhibitors Industry Trends
  2. 2.2 PD-1/PD-L1 Checkpoint Inhibitors Industry Drivers
  3. 2.3 PD-1/PD-L1 Checkpoint Inhibitors Industry Opportunities and Challenges
  4. 2.4 PD-1/PD-L1 Checkpoint Inhibitors Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by PD-1/PD-L1 Checkpoint Inhibitors Revenue (2021-2026)
  2. 3.2 Global Top Players by PD-1/PD-L1 Checkpoint Inhibitors Sales (2021-2026)
  3. 3.3 Global Top Players by PD-1/PD-L1 Checkpoint Inhibitors Price (2021-2026)
  4. 3.4 Global PD-1/PD-L1 Checkpoint Inhibitors Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global PD-1/PD-L1 Checkpoint Inhibitors Major Company Production Sites & Headquarters
  6. 3.6 Global PD-1/PD-L1 Checkpoint Inhibitors Company, Product Type & Application
  7. 3.7 Global PD-1/PD-L1 Checkpoint Inhibitors Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global PD-1/PD-L1 Checkpoint Inhibitors Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 PD-1/PD-L1 Checkpoint Inhibitors Players Market Share by Revenue in 2025
  11. 3.8.3 2025 PD-1/PD-L1 Checkpoint Inhibitors Tier 1, Tier 2, and Tier 3
4 PD-1/PD-L1 Checkpoint Inhibitors Regional Status and Outlook
  1. 4.1 Global PD-1/PD-L1 Checkpoint Inhibitors Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global PD-1/PD-L1 Checkpoint Inhibitors Historic Market Size by Region
  3. 4.2.1 Global PD-1/PD-L1 Checkpoint Inhibitors Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global PD-1/PD-L1 Checkpoint Inhibitors Sales in Value by Region (2021-2026)
  5. 4.2.3 Global PD-1/PD-L1 Checkpoint Inhibitors Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global PD-1/PD-L1 Checkpoint Inhibitors Forecasted Market Size by Region
  7. 4.3.1 Global PD-1/PD-L1 Checkpoint Inhibitors Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global PD-1/PD-L1 Checkpoint Inhibitors Sales in Value by Region (2027-2032)
  9. 4.3.3 Global PD-1/PD-L1 Checkpoint Inhibitors Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 PD-1/PD-L1 Checkpoint Inhibitors by Application
  1. 5.1 PD-1/PD-L1 Checkpoint Inhibitors Market by Application
  2. 5.1.1 Gastric Cancer
  3. 5.1.2 Squamous Cell Skin Cancer
  4. 5.1.3 Melanoma
  5. 5.1.4 Non-small Cell Lung Cancer
  6. 5.1.5 Other
  7. 5.2 Global PD-1/PD-L1 Checkpoint Inhibitors Market Size by Application
  8. 5.2.1 Global PD-1/PD-L1 Checkpoint Inhibitors Market Size Overview by Application (2021-2032)
  9. 5.2.2 Global PD-1/PD-L1 Checkpoint Inhibitors Historic Market Size Review by Application (2021-2026)
  10. 5.2.3 Global PD-1/PD-L1 Checkpoint Inhibitors Forecasted Market Size by Application (2027-2032)
  11. 5.3 Key Regions Market Size by Application
  12. 5.3.1 North America PD-1/PD-L1 Checkpoint Inhibitors Sales Breakdown by Application (2021-2026)
  13. 5.3.2 Europe PD-1/PD-L1 Checkpoint Inhibitors Sales Breakdown by Application (2021-2026)
  14. 5.3.3 Asia-Pacific PD-1/PD-L1 Checkpoint Inhibitors Sales Breakdown by Application (2021-2026)
  15. 5.3.4 South America PD-1/PD-L1 Checkpoint Inhibitors Sales Breakdown by Application (2021-2026)
  16. 5.3.5 Middle East and Africa PD-1/PD-L1 Checkpoint Inhibitors Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Merck
  2. 6.1.1 Merck Company Information
  3. 6.1.2 Merck Business Overview
  4. 6.1.3 Merck PD-1/PD-L1 Checkpoint Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Merck PD-1/PD-L1 Checkpoint Inhibitors Product Portfolio
  6. 6.1.5 Merck Recent Developments
  7. 6.2 Junshi Biosciences
  8. 6.2.1 Junshi Biosciences Company Information
  9. 6.2.2 Junshi Biosciences Business Overview
  10. 6.2.3 Junshi Biosciences PD-1/PD-L1 Checkpoint Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Junshi Biosciences PD-1/PD-L1 Checkpoint Inhibitors Product Portfolio
  12. 6.2.5 Junshi Biosciences Recent Developments
  13. 6.3 Pfizer
  14. 6.3.1 Pfizer Company Information
  15. 6.3.2 Pfizer Business Overview
  16. 6.3.3 Pfizer PD-1/PD-L1 Checkpoint Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Pfizer PD-1/PD-L1 Checkpoint Inhibitors Product Portfolio
  18. 6.3.5 Pfizer Recent Developments
  19. 6.4 Hengrui Pharmaceuticals
  20. 6.4.1 Hengrui Pharmaceuticals Company Information
  21. 6.4.2 Hengrui Pharmaceuticals Business Overview
  22. 6.4.3 Hengrui Pharmaceuticals PD-1/PD-L1 Checkpoint Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Hengrui Pharmaceuticals PD-1/PD-L1 Checkpoint Inhibitors Product Portfolio
  24. 6.4.5 Hengrui Pharmaceuticals Recent Developments
  25. 6.5 Roche
  26. 6.5.1 Roche Company Information
  27. 6.5.2 Roche Business Overview
  28. 6.5.3 Roche PD-1/PD-L1 Checkpoint Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Roche PD-1/PD-L1 Checkpoint Inhibitors Product Portfolio
  30. 6.5.5 Roche Recent Developments
  31. 6.6 Regeneron Pharmaceuticals
  32. 6.6.1 Regeneron Pharmaceuticals Company Information
  33. 6.6.2 Regeneron Pharmaceuticals Business Overview
  34. 6.6.3 Regeneron Pharmaceuticals PD-1/PD-L1 Checkpoint Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Regeneron Pharmaceuticals PD-1/PD-L1 Checkpoint Inhibitors Product Portfolio
  36. 6.6.5 Regeneron Pharmaceuticals Recent Developments
  37. 6.7 Bristol Myers Squibb
  38. 6.7.1 Bristol Myers Squibb Company Information
  39. 6.7.2 Bristol Myers Squibb Business Overview
  40. 6.7.3 Bristol Myers Squibb PD-1/PD-L1 Checkpoint Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Bristol Myers Squibb PD-1/PD-L1 Checkpoint Inhibitors Product Portfolio
  42. 6.7.5 Bristol Myers Squibb Recent Developments
  43. 6.8 AstraZeneca
  44. 6.8.1 AstraZeneca Company Information
  45. 6.8.2 AstraZeneca Business Overview
  46. 6.8.3 AstraZeneca PD-1/PD-L1 Checkpoint Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 AstraZeneca PD-1/PD-L1 Checkpoint Inhibitors Product Portfolio
  48. 6.8.5 AstraZeneca Recent Developments
7 North America by Country
  1. 7.1 North America PD-1/PD-L1 Checkpoint Inhibitors Sales by Country
  2. 7.1.1 North America PD-1/PD-L1 Checkpoint Inhibitors Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America PD-1/PD-L1 Checkpoint Inhibitors Sales by Country (2021-2026)
  4. 7.1.3 North America PD-1/PD-L1 Checkpoint Inhibitors Sales Forecast by Country (2027-2032)
  5. 7.2 North America PD-1/PD-L1 Checkpoint Inhibitors Market Size by Country
  6. 7.2.1 North America PD-1/PD-L1 Checkpoint Inhibitors Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America PD-1/PD-L1 Checkpoint Inhibitors Market Size by Country (2021-2026)
  8. 7.2.3 North America PD-1/PD-L1 Checkpoint Inhibitors Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe PD-1/PD-L1 Checkpoint Inhibitors Sales by Country
  2. 8.1.1 Europe PD-1/PD-L1 Checkpoint Inhibitors Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe PD-1/PD-L1 Checkpoint Inhibitors Sales by Country (2021-2026)
  4. 8.1.3 Europe PD-1/PD-L1 Checkpoint Inhibitors Sales Forecast by Country (2027-2032)
  5. 8.2 Europe PD-1/PD-L1 Checkpoint Inhibitors Market Size by Country
  6. 8.2.1 Europe PD-1/PD-L1 Checkpoint Inhibitors Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe PD-1/PD-L1 Checkpoint Inhibitors Market Size by Country (2021-2026)
  8. 8.2.3 Europe PD-1/PD-L1 Checkpoint Inhibitors Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific PD-1/PD-L1 Checkpoint Inhibitors Sales by Country
  2. 9.1.1 Asia-Pacific PD-1/PD-L1 Checkpoint Inhibitors Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific PD-1/PD-L1 Checkpoint Inhibitors Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific PD-1/PD-L1 Checkpoint Inhibitors Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific PD-1/PD-L1 Checkpoint Inhibitors Market Size by Country
  6. 9.2.1 Asia-Pacific PD-1/PD-L1 Checkpoint Inhibitors Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific PD-1/PD-L1 Checkpoint Inhibitors Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific PD-1/PD-L1 Checkpoint Inhibitors Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America PD-1/PD-L1 Checkpoint Inhibitors Sales by Country
  2. 10.1.1 South America PD-1/PD-L1 Checkpoint Inhibitors Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America PD-1/PD-L1 Checkpoint Inhibitors Sales by Country (2021-2026)
  4. 10.1.3 South America PD-1/PD-L1 Checkpoint Inhibitors Sales Forecast by Country (2027-2032)
  5. 10.2 South America PD-1/PD-L1 Checkpoint Inhibitors Market Size by Country
  6. 10.2.1 South America PD-1/PD-L1 Checkpoint Inhibitors Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America PD-1/PD-L1 Checkpoint Inhibitors Market Size by Country (2021-2026)
  8. 10.2.3 South America PD-1/PD-L1 Checkpoint Inhibitors Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa PD-1/PD-L1 Checkpoint Inhibitors Sales by Country
  2. 11.1.1 Middle East and Africa PD-1/PD-L1 Checkpoint Inhibitors Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa PD-1/PD-L1 Checkpoint Inhibitors Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa PD-1/PD-L1 Checkpoint Inhibitors Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa PD-1/PD-L1 Checkpoint Inhibitors Market Size by Country
  6. 11.2.1 Middle East and Africa PD-1/PD-L1 Checkpoint Inhibitors Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa PD-1/PD-L1 Checkpoint Inhibitors Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa PD-1/PD-L1 Checkpoint Inhibitors Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 PD-1/PD-L1 Checkpoint Inhibitors Value Chain Analysis
  2. 12.1.1 PD-1/PD-L1 Checkpoint Inhibitors Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 PD-1/PD-L1 Checkpoint Inhibitors Production Mode & Process
  7. 12.2 PD-1/PD-L1 Checkpoint Inhibitors Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 PD-1/PD-L1 Checkpoint Inhibitors Distributors
  10. 12.2.3 PD-1/PD-L1 Checkpoint Inhibitors Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst